Toril Holien
About
Research focus: TGF-β family signaling in cancer
Our research is focused on understanding the role of transforming growth factor (TGF)-ß family signaling pathways in multiple myeloma and other cancers. This includes ligands such as TGF-ß, activins, BMPs and GDFs. There is extensive redundancy in this family of ligands and receptors, and the effects of a given molecule will always depend on the context. Activation of the SMAD1/5 transcription factors by TGF-ß family ligands induces apoptosis in myeloma cells by downregulating the oncogene c-MYC. Potentiaion of SMAD1/5 activity represents therefore a possible treatment option for myeloma patients. We are also interested in the role of TGF-ß signaling in the context of the tumor microenvironment, particularly in relation to angiogenesis and dissemination.
We welcome students that want to study regulation of signaling in the TGF-ß family.
Research
Research focus: TGF-β family signaling in multiple myeloma and other cancers
Our research is focused on understanding the role of transforming growth factor (TGF)-ß family signaling pathways in multiple myeloma and other cancers. This includes ligands such as TGF-ß, activins, BMPs and GDFs. There is extensive redundancy in this family of ligands and receptors, and the effects of a given molecule will always depend on the context. Activation of the SMAD1/5 transcription factors by TGF-ß family ligands induces apoptosis in myeloma cells by downregulating the oncogene c-MYC. Potentiaion of SMAD1/5 activity represents therefore a possible treatment option for myeloma patients. We are also interested in the role of TGF-ß signaling in the context of the tumor microenvironment, particularly in relation to angiogenesis and dissemination.
We welcome students that want to study regulation of signaling in the TGF-ß family.
Students
PhD student, MD: Ingrid Quist-Løkken
PhD student: Md Abu Hanif (Edan)
PhD student: Eli Svorkdal Hess
PhD student, MD: Ingrid Quist-Løkken
PhD student: Md Abu Hanif (Edan)
PhD student: Eli Svorkdal Hess
Master student: Hedda Haakonsen
Master student: Ingrid Sæternes Kvitsand
Bachelor/Erasmus student: Lucas Blixt
Former students and coworkers
PhD student (2024): Clara Andersson-Rusch
Post doctor (2020): Oddrun Elise Olsen
PhD (2017): Oddrun Elise Olsen
PhD (2020, cosupervised): Camilla Wolowczyk
PhD (2017): Oddrun Elise Olsen
PhD (2020, cosupervised): Camilla Wolowczyk
Master level:
Molecular medicine (2023/24): Johanna Møen
Molecular medicine (2021/22, co-supervised): Bita Asghariastanehei
Molecular medicine (2020/21): Megan Anne Vik and Lu Bai
Biotechnology (2019/20, cosupervised): Jenny Malm Rasmussen
Pharmacy (2018/19): Martin Haugrud Kastnes, Nerissa Rae Booc
Pharmacy (2017/18): Thi Le, Fartun Hussein Ali
Molecular Medicine (2016/17): Samah Elsaadi, Fekadu Alemu Atire
Biotechnology (2013/15): Anette Skjærvik
Cell biology (2012/14): Kine Husteli Kristiansen
Biotechnology (2011/12): Oddrun Elise Olsen
Biotechnology (2019/20, cosupervised): Jenny Malm Rasmussen
Pharmacy (2018/19): Martin Haugrud Kastnes, Nerissa Rae Booc
Pharmacy (2017/18): Thi Le, Fartun Hussein Ali
Molecular Medicine (2016/17): Samah Elsaadi, Fekadu Alemu Atire
Biotechnology (2013/15): Anette Skjærvik
Cell biology (2012/14): Kine Husteli Kristiansen
Biotechnology (2011/12): Oddrun Elise Olsen
Erasmus trainee students:
Naiara Campos Roman (master thesis, 2024)
Ella Thorgren (bachelor thesis, 2024)
Wilma Wadman (bachelor thesis, 2023)
Alexander Stockhammer (master level, 2018)
Marie-Thérèse Henke (bachelor level, 2017)
Meenu Sankar (master thesis, 2015/16)
Sarah Nevens (bachelor level, 2013/14)
Marie-Thérèse Henke (bachelor level, 2017)
Meenu Sankar (master thesis, 2015/16)
Sarah Nevens (bachelor level, 2013/14)
Publications
Receptor binding competition: A paradigm for regulating TGF-β family action
A striking feature of the TGF-β family is its promiscuity, i.e., many ligands compete for binding to the same receptors. Here, we discuss ligand-receptor competition and how ligands can function as agonists or antagonists depending on cellular context.
FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells
FKBP12 interacts with TGF-β type I receptors, such as ALK2. We found that FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells, partly by switching an NSC into an active signaling complex, but also be potentiating all activity via ALK2.
Cell surface marker heterogeneity in human myeloma cell lines for modeling of disease and therapy
Myeloma cell lines are important tools in myeloma research. Their use depends on resemblance to patient-derived cells. We compared cell surface marker expression in cell lines (protein + mRNA) with patient cell transcriptomic data (CoMMpass data set).
2024
-
Christensen, Eidi;
Foss, Olav A.;
Holien, Toril;
Juzenas, Petras;
Qian, Peng.
(2024)
Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Cutaneous T-Cell Lymphoma: A First-in-Human Phase I/II Study.
Pharmaceutics
Academic article
-
Behsen, Alenka Djarmila;
Holien, Toril;
Micci, Francesca;
Rye, Morten Beck;
Rasmussen, Jenny Malm;
Andersen, Kristin.
(2024)
Cell surface marker heterogeneity in human myeloma cell lines for modeling of disease and therapy.
Scientific Reports
Academic article
2023
-
Quist-Løkken, Ingrid;
Andersson-Rusch, Clara Leticia;
Kastnes, Martin Haugrud;
Kolos, Jürgen Markus;
Jatzlau, Jerome;
Hella, Hanne.
(2023)
FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells.
Cell Communication and Signaling
Academic article
-
Andersson-Rusch, Clara Leticia;
Liu, Bin;
Quist-Løkken, Ingrid;
Upton, Paul D.;
Olsen, Oddrun Elise;
Hella, Hanne.
(2023)
High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells.
Scientific Reports
Academic article
2022
-
Giliberto, Mariaserena;
Miranda Santana, Leonardo;
Holien, Toril;
Misund, Kristine;
Nakken, Sigve;
Vodak, Daniel.
(2022)
Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines.
Frontiers in Oncology
Academic article
2021
-
Kolos, Jürgen M;
Pomplun, Sebastian;
Jung, Sascha;
Rieß, Benedikt;
Purder, Patrick L;
Voll, Andreas M.
(2021)
Picomolar FKBP inhibitors enabled by a single water-displacing methyl group in bicyclic [4.3.1] aza-amides.
Chemical Science
Academic article
-
Melvold, Katrine;
Giliberto, Mariaserena;
Karlsen, Linda;
Ayuda-Duran, Maria del Pilar;
Hanes, Robert;
Holien, Toril.
(2021)
Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B-cell malignancies.
Molecular Oncology
Academic article
-
Christensen, Eidi;
Foss, Olav A.;
Quist-Paulsen, Petter;
Staur, Ingrid;
Pettersen, Frode;
Holien, Toril.
(2021)
Application of photodynamic therapy with 5-aminolevulinic acid to extracorporeal photopheresis in the treatment of patients with chronic graft-versus-host disease: A first-in-human study.
Pharmaceutics
Academic article
2020
-
Olsen, Oddrun Elise;
Hella, Hanne;
Elsaadi, Samah;
Jacobi, Carsten;
Martinez-Hackert, Erik;
Holien, Toril.
(2020)
Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors.
Biomolecules
Academic article
-
Westhrin, Marita;
Holien, Toril;
Zahoor, Muhammad;
Moen, Siv Helen;
Buene, Glenn;
Størdal, Berit Fladvad.
(2020)
Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone.
JBMR Plus
Academic article
-
Darvekar, Sagar;
Juzenas, Petras;
Oksvold, Morten Pedersen;
Kleinauskas, Andrius;
Holien, Toril;
Christensen, Eidi.
(2020)
Selective Killing of Activated T Cells by 5-Aminolevulinic Acid Mediated Photodynamic Effect: Potential Improvement of Extracorporeal Photopheresis.
Cancers
Academic article
-
Martinez-Hackert, Erik;
Sundan, Anders;
Holien, Toril.
(2020)
Receptor binding competition: A paradigm for regulating TGF-β family action.
Cytokine & growth factor reviews
Academic literature review
-
Ianevski, Aleksandr;
Kulesskiy, Evgeny;
Krpina, Klara;
Lou, Guofeng;
Aman, Yahyah;
Bugai, Andrii.
(2020)
Chemical, Physical and Biological Triggers of Evolutionary Sonserved Bcl-xL-Mediated Apoptosis.
Cancers
Academic article
2019
-
Neckmann, Ulrike;
Wolowczyk, Camilla;
Hall, Martina;
Almaas, Eivind;
Ren, Jiang;
Zhao, Sen.
(2019)
GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients.
Cell Communication and Signaling
Academic article
2018
-
Olsen, Oddrun Elise;
Sankar, Meenu;
Elsaadi, Samah;
Hella, Hanne;
Buene, Glenn;
Darvekar, Sagar.
(2018)
BMPR2 inhibits activin and BMP signaling via wild-type ALK2.
Journal of Cell Science
Academic article
-
Holien, Toril;
Gederaas, Odrun Arna;
Darvekar, Sagar;
Christensen, Eidi;
Qian, Peng.
(2018)
Comparison Between 8-Methoxypsoralen and
5-Aminolevulinic Acid in Killing T Cells of Photopheresis
Patients Ex Vivo.
Lasers in Surgery and Medicine
Academic article
-
Våtsveen, Thea Kristin;
Myhre, Marit Renee;
Steen, Chloe Beate;
Wälchli, Sébastien;
Lingjærde, Ole Christian;
Bai, Baoyan.
(2018)
Artesunate shows potent anti-tumor activity in B-cell lymphoma.
Journal of Hematology & Oncology
Academic article
2017
-
Olsen, Oddrun Elise;
Holien, Toril;
Sundan, Anders.
(2017)
The role of BMP receptor ALK2 in myeloma cells.
Norwegian University of Science and Technology
Doctoral dissertation
-
Olsen, Oddrun Elise;
Skjærvik, Anette;
Størdal, Berit Fladvad;
Sundan, Anders;
Holien, Toril.
(2017)
TGF-β contamination of purified recombinant GDF15.
PLOS ONE
Academic article
-
Rustad, Even Holth;
Coward, Eivind;
Skytøen, Emilie R;
Misund, Kristine;
Holien, Toril;
Standal, Therese.
(2017)
Monitoring multiple myeloma by quantification of recurrent mutations in serum.
Haematologica
Academic article
-
Tangen, Jon-Magnus;
Holien, Toril;
Mirlashari, Mohammad Reza;
Misund, Kristine;
Hetland, Geir.
(2017)
Cytotoxic Effect on Human Myeloma Cells and Leukemic Cells by the Agaricus blazei Murill Based Mushroom Extract, Andosan™.
BioMed Research International
Academic article
2016
-
Baranowska, Katarzyna Anna;
Misund, Kristine;
Starheim, Kristian K.;
Holien, Toril;
Johansson, Ida;
Darvekar, Sagar.
(2016)
Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells.
OncoTarget
Academic article
-
Våtsveen, Thea Kristin;
Børset, Magne;
Dikic, Aida;
Tian, Erming;
Micci, Francesca;
Lid, Ana Barragan.
(2016)
VOLIN and KJON—Two novel hyperdiploid myeloma cell lines.
Genes, Chromosomes and Cancer
Academic article
-
Abdollahi, Pegah;
Vandsemb, Esten Nymoen;
Hjort, Magnus Aassved;
Misund, Kristine;
Holien, Toril;
Sponaas, Anne-Marit.
(2016)
Src family kinases are regulated in multiple myeloma cells by phosphatase of regenerating liver-3.
Molecular Cancer Research
Academic article
-
Starheim, Kristian Kobbenes;
Holien, Toril;
Misund, Kristine;
Johansson, Ida;
Baranowska, Katarzyna Anna;
Sponaas, Anne Marit.
(2016)
Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells.
Blood Cancer Journal
Academic article
2015
-
Westhrin, Marita;
Moen, Siv Helen;
Holien, Toril;
Mylin, Anne K.;
Heickendorff, Lene;
Olsen, Oddrun Elise.
(2015)
Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease.
Haematologica
Letter to the editor
-
Misund, Kristine;
Baranowska, Katarzyna Anna;
Holien, Toril;
Starheim, Kristian K.;
Johansson, Ida;
Buene, Glenn.
(2015)
Chloroquine potentiates Carfilzomib but not Bortezomib effects on myeloma cells.
Cancer Research
Abstract
-
Wang, Huabo;
Teriete, Peter;
Hu, Angela;
Raveendra-Panickar, Dhanya;
Pendelton, Kelsey;
Lazo, John S.
(2015)
Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids.
OncoTarget
Academic article
-
Jung, Kwan-Young;
Wang, Huabo;
Teriete, Peter;
Yap, Jeremy L;
Chen, Lijia;
Lanning, Maryanna E.
(2015)
Perturbation of the c-Myc-Max Protein-Protein Interaction via Synthetic α-Helix Mimetics.
Journal of Medicinal Chemistry
Academic article
-
Sponaas, Anne-Marit;
Moen, Siv Helen;
Liabakk, Nina-Beate;
Feyzi, Emadoldin;
Holien, Toril;
Kvam, Solveig.
(2015)
The proportion of CD16+CD14dim monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma.
Immunity,Inflammation and Disease
Academic article
-
Olsen, Oddrun Elise;
Wader, Karin Fahl;
Hella, Hanne;
Mylin, Anne K.;
Turesson, Ingemar;
Nesthus, Ingerid.
(2015)
Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B.
Cell Communication and Signaling
Academic article
-
Holien, Toril;
Misund, Kristine;
Olsen, Oddrun Elise;
Baranowska, Katarzyna Anna;
Buene, Glenn;
Børset, Magne.
(2015)
MYC amplifications in myeloma cell lines: Correlation with MYC-inhibitor efficacy.
OncoTarget
Academic article
2014
-
Holien, Toril;
Sundan, Anders.
(2014)
The role of bone morphogenetic proteins in myeloma cell survival.
Cytokine & growth factor reviews
Academic literature review
-
Olsen, Oddrun Elise;
Wader, Karin Fahl;
Misund, Kristine;
Våtsveen, Thea Kristin;
Rø, Torstein Baade;
Mylin, Anne K..
(2014)
Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.
Blood Cancer Journal
Academic article
2013
-
Müller, Rebekka;
Misund, Kristine;
Holien, Toril;
Bachke, Siri;
Gilljam, Karin Margaretha;
Våtsveen, Thea Kristin.
(2013)
Targeting Proliferating Cell Nuclear Antigen and Its Protein Interactions Induces Apoptosis in Multiple Myeloma Cells.
PLOS ONE
Academic article
-
Holien, Toril;
Olsen, Oddrun Elise;
Misund, Kristine;
Hella, Hanne;
Waage, Anders;
Rø, Torstein Baade.
(2013)
Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate.
European Journal of Haematology
Academic article
-
Misund, Kristine;
Baranowska, Katarzyna Anna;
Holien, Toril;
Rampa, Christoph Samuel;
Klein, Dionne;
Børset, Magne.
(2013)
A method for measurement of drug sensitivity of myeloma cells co-cultured with bone marrow stromal cells.
Journal of Biomolecular Screening
Academic article
-
Rø, Torstein Baade;
Holien, Toril;
Fagerli, Unn-Merete;
Hov, Håkon;
Misund, Kristine;
Waage, Anders.
(2013)
HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase.
Experimental Hematology
Academic article
2012
-
Holien, Toril;
Våtsveen, Thea Kristin;
Hella, Hanne;
Rampa, Christoph Samuel;
Brede, Gaute;
Grøseth, Lill Anny Gunnes.
(2012)
Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC.
Leukemia
Academic article
-
Olsen, Oddrun Elise;
Holien, Toril.
(2012)
The role of bone morphogenetic protein-9 in multiple myeloma.
Norwegian University of Science and Technology
Masters thesis
-
Holien, Toril;
Våtsveen, Thea Kristin;
Hella, Hanne;
Waage, Anders;
Sundan, Anders.
(2012)
Addiction to c-MYC in multiple myeloma.
Blood
Academic article
2011
-
Fagerli, Unn-Merete;
Ullrich, K;
Stühmer, Thorsten;
Holien, Toril;
Köchert, K;
Holt, Randi Utne.
(2011)
Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells.
Oncogene
Academic article
2010
-
Nørgaard, Nikolai Nordberg;
Holien, Toril;
Jonsson, Sofia;
Hella, Hanne;
Espevik, Terje;
Sundan, Anders.
(2010)
CpG-Oligodeoxynucleotide Inhibits Smad-Dependent Bone Morphogenetic Protein Signaling: Effects on Myeloma Cell Apoptosis and In Vitro Osteoblastogenesis.
Journal of Immunology
Academic article
2009
-
Hov, Håkon;
Tian, Erming;
Holien, Toril;
Holt, Randi Utne;
Våtsveen, Thea;
Fagerli, Unn-Merete.
(2009)
c-Met signaling promotes IL-6-induced myeloma cell proliferation.
European Journal of Haematology
Academic article
2008
-
Fagerli, Unn-Merete;
Holt, Randi Utne;
Holien, Toril;
Våtsveen, Toril;
Zhan, Fenghuang;
Egeberg, Kjartan.
(2008)
Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells.
Blood
Academic article
2000
-
Munthe, Else;
Rian, Edith;
Holien, T.;
Rasmussen, Anne Marie;
Levy, Finn Olav;
Aasheim, Hans-Christian.
(2000)
Ephrin-B2 is a candidate ligand for the Eph repceotr, Eph6.
FEBS Letters
Academic article
Journal publications
-
Christensen, Eidi;
Foss, Olav A.;
Holien, Toril;
Juzenas, Petras;
Qian, Peng.
(2024)
Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Cutaneous T-Cell Lymphoma: A First-in-Human Phase I/II Study.
Pharmaceutics
Academic article
-
Behsen, Alenka Djarmila;
Holien, Toril;
Micci, Francesca;
Rye, Morten Beck;
Rasmussen, Jenny Malm;
Andersen, Kristin.
(2024)
Cell surface marker heterogeneity in human myeloma cell lines for modeling of disease and therapy.
Scientific Reports
Academic article
-
Quist-Løkken, Ingrid;
Andersson-Rusch, Clara Leticia;
Kastnes, Martin Haugrud;
Kolos, Jürgen Markus;
Jatzlau, Jerome;
Hella, Hanne.
(2023)
FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells.
Cell Communication and Signaling
Academic article
-
Andersson-Rusch, Clara Leticia;
Liu, Bin;
Quist-Løkken, Ingrid;
Upton, Paul D.;
Olsen, Oddrun Elise;
Hella, Hanne.
(2023)
High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells.
Scientific Reports
Academic article
-
Giliberto, Mariaserena;
Miranda Santana, Leonardo;
Holien, Toril;
Misund, Kristine;
Nakken, Sigve;
Vodak, Daniel.
(2022)
Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines.
Frontiers in Oncology
Academic article
-
Kolos, Jürgen M;
Pomplun, Sebastian;
Jung, Sascha;
Rieß, Benedikt;
Purder, Patrick L;
Voll, Andreas M.
(2021)
Picomolar FKBP inhibitors enabled by a single water-displacing methyl group in bicyclic [4.3.1] aza-amides.
Chemical Science
Academic article
-
Melvold, Katrine;
Giliberto, Mariaserena;
Karlsen, Linda;
Ayuda-Duran, Maria del Pilar;
Hanes, Robert;
Holien, Toril.
(2021)
Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B-cell malignancies.
Molecular Oncology
Academic article
-
Christensen, Eidi;
Foss, Olav A.;
Quist-Paulsen, Petter;
Staur, Ingrid;
Pettersen, Frode;
Holien, Toril.
(2021)
Application of photodynamic therapy with 5-aminolevulinic acid to extracorporeal photopheresis in the treatment of patients with chronic graft-versus-host disease: A first-in-human study.
Pharmaceutics
Academic article
-
Olsen, Oddrun Elise;
Hella, Hanne;
Elsaadi, Samah;
Jacobi, Carsten;
Martinez-Hackert, Erik;
Holien, Toril.
(2020)
Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors.
Biomolecules
Academic article
-
Westhrin, Marita;
Holien, Toril;
Zahoor, Muhammad;
Moen, Siv Helen;
Buene, Glenn;
Størdal, Berit Fladvad.
(2020)
Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone.
JBMR Plus
Academic article
-
Darvekar, Sagar;
Juzenas, Petras;
Oksvold, Morten Pedersen;
Kleinauskas, Andrius;
Holien, Toril;
Christensen, Eidi.
(2020)
Selective Killing of Activated T Cells by 5-Aminolevulinic Acid Mediated Photodynamic Effect: Potential Improvement of Extracorporeal Photopheresis.
Cancers
Academic article
-
Martinez-Hackert, Erik;
Sundan, Anders;
Holien, Toril.
(2020)
Receptor binding competition: A paradigm for regulating TGF-β family action.
Cytokine & growth factor reviews
Academic literature review
-
Ianevski, Aleksandr;
Kulesskiy, Evgeny;
Krpina, Klara;
Lou, Guofeng;
Aman, Yahyah;
Bugai, Andrii.
(2020)
Chemical, Physical and Biological Triggers of Evolutionary Sonserved Bcl-xL-Mediated Apoptosis.
Cancers
Academic article
-
Neckmann, Ulrike;
Wolowczyk, Camilla;
Hall, Martina;
Almaas, Eivind;
Ren, Jiang;
Zhao, Sen.
(2019)
GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients.
Cell Communication and Signaling
Academic article
-
Olsen, Oddrun Elise;
Sankar, Meenu;
Elsaadi, Samah;
Hella, Hanne;
Buene, Glenn;
Darvekar, Sagar.
(2018)
BMPR2 inhibits activin and BMP signaling via wild-type ALK2.
Journal of Cell Science
Academic article
-
Holien, Toril;
Gederaas, Odrun Arna;
Darvekar, Sagar;
Christensen, Eidi;
Qian, Peng.
(2018)
Comparison Between 8-Methoxypsoralen and
5-Aminolevulinic Acid in Killing T Cells of Photopheresis
Patients Ex Vivo.
Lasers in Surgery and Medicine
Academic article
-
Våtsveen, Thea Kristin;
Myhre, Marit Renee;
Steen, Chloe Beate;
Wälchli, Sébastien;
Lingjærde, Ole Christian;
Bai, Baoyan.
(2018)
Artesunate shows potent anti-tumor activity in B-cell lymphoma.
Journal of Hematology & Oncology
Academic article
-
Olsen, Oddrun Elise;
Skjærvik, Anette;
Størdal, Berit Fladvad;
Sundan, Anders;
Holien, Toril.
(2017)
TGF-β contamination of purified recombinant GDF15.
PLOS ONE
Academic article
-
Rustad, Even Holth;
Coward, Eivind;
Skytøen, Emilie R;
Misund, Kristine;
Holien, Toril;
Standal, Therese.
(2017)
Monitoring multiple myeloma by quantification of recurrent mutations in serum.
Haematologica
Academic article
-
Tangen, Jon-Magnus;
Holien, Toril;
Mirlashari, Mohammad Reza;
Misund, Kristine;
Hetland, Geir.
(2017)
Cytotoxic Effect on Human Myeloma Cells and Leukemic Cells by the Agaricus blazei Murill Based Mushroom Extract, Andosan™.
BioMed Research International
Academic article
-
Baranowska, Katarzyna Anna;
Misund, Kristine;
Starheim, Kristian K.;
Holien, Toril;
Johansson, Ida;
Darvekar, Sagar.
(2016)
Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells.
OncoTarget
Academic article
-
Våtsveen, Thea Kristin;
Børset, Magne;
Dikic, Aida;
Tian, Erming;
Micci, Francesca;
Lid, Ana Barragan.
(2016)
VOLIN and KJON—Two novel hyperdiploid myeloma cell lines.
Genes, Chromosomes and Cancer
Academic article
-
Abdollahi, Pegah;
Vandsemb, Esten Nymoen;
Hjort, Magnus Aassved;
Misund, Kristine;
Holien, Toril;
Sponaas, Anne-Marit.
(2016)
Src family kinases are regulated in multiple myeloma cells by phosphatase of regenerating liver-3.
Molecular Cancer Research
Academic article
-
Starheim, Kristian Kobbenes;
Holien, Toril;
Misund, Kristine;
Johansson, Ida;
Baranowska, Katarzyna Anna;
Sponaas, Anne Marit.
(2016)
Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells.
Blood Cancer Journal
Academic article
-
Westhrin, Marita;
Moen, Siv Helen;
Holien, Toril;
Mylin, Anne K.;
Heickendorff, Lene;
Olsen, Oddrun Elise.
(2015)
Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease.
Haematologica
Letter to the editor
-
Misund, Kristine;
Baranowska, Katarzyna Anna;
Holien, Toril;
Starheim, Kristian K.;
Johansson, Ida;
Buene, Glenn.
(2015)
Chloroquine potentiates Carfilzomib but not Bortezomib effects on myeloma cells.
Cancer Research
Abstract
-
Wang, Huabo;
Teriete, Peter;
Hu, Angela;
Raveendra-Panickar, Dhanya;
Pendelton, Kelsey;
Lazo, John S.
(2015)
Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids.
OncoTarget
Academic article
-
Jung, Kwan-Young;
Wang, Huabo;
Teriete, Peter;
Yap, Jeremy L;
Chen, Lijia;
Lanning, Maryanna E.
(2015)
Perturbation of the c-Myc-Max Protein-Protein Interaction via Synthetic α-Helix Mimetics.
Journal of Medicinal Chemistry
Academic article
-
Sponaas, Anne-Marit;
Moen, Siv Helen;
Liabakk, Nina-Beate;
Feyzi, Emadoldin;
Holien, Toril;
Kvam, Solveig.
(2015)
The proportion of CD16+CD14dim monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma.
Immunity,Inflammation and Disease
Academic article
-
Olsen, Oddrun Elise;
Wader, Karin Fahl;
Hella, Hanne;
Mylin, Anne K.;
Turesson, Ingemar;
Nesthus, Ingerid.
(2015)
Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B.
Cell Communication and Signaling
Academic article
-
Holien, Toril;
Misund, Kristine;
Olsen, Oddrun Elise;
Baranowska, Katarzyna Anna;
Buene, Glenn;
Børset, Magne.
(2015)
MYC amplifications in myeloma cell lines: Correlation with MYC-inhibitor efficacy.
OncoTarget
Academic article
-
Holien, Toril;
Sundan, Anders.
(2014)
The role of bone morphogenetic proteins in myeloma cell survival.
Cytokine & growth factor reviews
Academic literature review
-
Olsen, Oddrun Elise;
Wader, Karin Fahl;
Misund, Kristine;
Våtsveen, Thea Kristin;
Rø, Torstein Baade;
Mylin, Anne K..
(2014)
Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.
Blood Cancer Journal
Academic article
-
Müller, Rebekka;
Misund, Kristine;
Holien, Toril;
Bachke, Siri;
Gilljam, Karin Margaretha;
Våtsveen, Thea Kristin.
(2013)
Targeting Proliferating Cell Nuclear Antigen and Its Protein Interactions Induces Apoptosis in Multiple Myeloma Cells.
PLOS ONE
Academic article
-
Holien, Toril;
Olsen, Oddrun Elise;
Misund, Kristine;
Hella, Hanne;
Waage, Anders;
Rø, Torstein Baade.
(2013)
Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate.
European Journal of Haematology
Academic article
-
Misund, Kristine;
Baranowska, Katarzyna Anna;
Holien, Toril;
Rampa, Christoph Samuel;
Klein, Dionne;
Børset, Magne.
(2013)
A method for measurement of drug sensitivity of myeloma cells co-cultured with bone marrow stromal cells.
Journal of Biomolecular Screening
Academic article
-
Rø, Torstein Baade;
Holien, Toril;
Fagerli, Unn-Merete;
Hov, Håkon;
Misund, Kristine;
Waage, Anders.
(2013)
HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase.
Experimental Hematology
Academic article
-
Holien, Toril;
Våtsveen, Thea Kristin;
Hella, Hanne;
Rampa, Christoph Samuel;
Brede, Gaute;
Grøseth, Lill Anny Gunnes.
(2012)
Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC.
Leukemia
Academic article
-
Holien, Toril;
Våtsveen, Thea Kristin;
Hella, Hanne;
Waage, Anders;
Sundan, Anders.
(2012)
Addiction to c-MYC in multiple myeloma.
Blood
Academic article
-
Fagerli, Unn-Merete;
Ullrich, K;
Stühmer, Thorsten;
Holien, Toril;
Köchert, K;
Holt, Randi Utne.
(2011)
Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells.
Oncogene
Academic article
-
Nørgaard, Nikolai Nordberg;
Holien, Toril;
Jonsson, Sofia;
Hella, Hanne;
Espevik, Terje;
Sundan, Anders.
(2010)
CpG-Oligodeoxynucleotide Inhibits Smad-Dependent Bone Morphogenetic Protein Signaling: Effects on Myeloma Cell Apoptosis and In Vitro Osteoblastogenesis.
Journal of Immunology
Academic article
-
Hov, Håkon;
Tian, Erming;
Holien, Toril;
Holt, Randi Utne;
Våtsveen, Thea;
Fagerli, Unn-Merete.
(2009)
c-Met signaling promotes IL-6-induced myeloma cell proliferation.
European Journal of Haematology
Academic article
-
Fagerli, Unn-Merete;
Holt, Randi Utne;
Holien, Toril;
Våtsveen, Toril;
Zhan, Fenghuang;
Egeberg, Kjartan.
(2008)
Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells.
Blood
Academic article
-
Munthe, Else;
Rian, Edith;
Holien, T.;
Rasmussen, Anne Marie;
Levy, Finn Olav;
Aasheim, Hans-Christian.
(2000)
Ephrin-B2 is a candidate ligand for the Eph repceotr, Eph6.
FEBS Letters
Academic article
Report
-
Olsen, Oddrun Elise;
Holien, Toril;
Sundan, Anders.
(2017)
The role of BMP receptor ALK2 in myeloma cells.
Norwegian University of Science and Technology
Doctoral dissertation
-
Olsen, Oddrun Elise;
Holien, Toril.
(2012)
The role of bone morphogenetic protein-9 in multiple myeloma.
Norwegian University of Science and Technology
Masters thesis
Teaching
Courses
- HBIOT3901 - Thesis in Molecular Medicine
- HBIOT2032 - Medical Laboratory Technology - Hematolgy and Hemostasis
- HBIOT2031 - Molecular diagnostics and applied bioinformatics
- HBIOT2035 - Bachelor thesis in Biomedical Laboratory Science
- HBIOT2026 - Medical Laboratory Technology - Transfusion Medicine and Immunohematology
Outreach
2025
-
PosterChristensen, Eidi; Foss, Olav A.; Holien, Toril; Juzenas, Petras; Qian, Peng. (2025) Extracorporeal Photopheresis with 5-Aminolevulinic Acid Photodynamic Therapy in Cutaneous T-cell Lymphoma; A First-in-Human Phase I/II study . NCDV 36th Nordic Congress of Dermatology and Venereology , Helsinki 2025-05-06 - 2025-05-09
2024
-
PosterHanif, Md Abu; Quist-Løkken, Ingrid; Andersson-Rusch, Clara Leticia; Holien, Toril. (2024) Selinexor potentiates BMP/SMAD-activity to induce apoptosis in multiple myeloma. Fedaration of American Societies for Experimental Biology FASEB: TGF-β Superfamily , Buffalo, New York 2024-07-21 - 2024-07-25
-
Academic lectureHolien, Toril. (2024) FKBP12 as a Gatekeeper of BMP Activity and Myeloma Cell Apoptosis. Samarbeidsmøte TU Darmstadt , Technische Universität Darmstadt 2024-11-07 - 2024-11-07
-
Academic lectureHolien, Toril. (2024) BMP Signaling and Transcription Factor Crosstalk in Myeloma Cell Apoptosis. FASEB TGF-β Superfamily , Niagara Falls, NY 2024-07-21 - 2024-07-25
-
PosterAndersson-Rusch, Clara; Quist-Løkken, Ingrid; Sætrom, Pål; Hanif, Md Abu; Rolinski, Milosz; Møen, Johanna. (2024) Whole genome CRISPR knockout screen reveals key function for ID3 in regulating myeloma cell survival via TCF3 and c-MYC. FASEB TGF-β Superfamily , Niagara Falls, NY 2024-07-21 - 2024-07-25
-
PosterQuist-Løkken, Ingrid; Tilseth, Mira; Hanif, Md Abu; Andersson-Rusch, Clara; Walz, Michael; Hausch, Felix. (2024) Novel FKBP12 targeting PROTACs enhances BMP-induced apoptosis in multiple myeloma. FASEB TGF-β Superfamily , Niagara Falls, NY 2024-07-21 - 2024-07-25
2023
-
Academic lectureHolien, Toril. (2023) Modulating bone morphogenetic protein activity in multiple myeloma cells. Elisa Migliorini, CEA Grenoble Mini-symposium: Decoding Glycosaminoglycans, Morphogens and Chemokines: intricate partners for intriguing functions , Grenoble 2023-10-20 - 2023-10-20
-
Academic lectureHolien, Toril. (2023) Ways of targeting ALK2 in multiple myeloma. 4th Norwegian Myeloma Workshop , Oslo 2023-11-02 - 2023-11-03
-
Academic lectureHolien, Toril. (2023) SABLe clinical trial - Update on translational project . NMSG Nordic Myeloma Study Group Autumn Meeting , Oslo 2023-09-13 - 2023-09-15
-
PosterAndersson-Rusch, Clara Leticia; Quist-Løkken, Ingrid; Sætrom, Pål; Beisvag, Vidar; Rolinski, Milosz; Møen, Johanna. (2023) Genome-Wide CRISPR/Cas9 Knock-out Screen Identifies Apoptosis-Relevant Genes in Multiple Myeloma. American Society of Hematology 65th ASH Annual Meeting and Exposition 2023-12-09 - 2023-12-12
-
PosterQuist-Løkken, Ingrid; Andersson-Rusch, Clara Leticia; Hanif, Md Abu; Tilseth, Mira-Celeste; Walz, Michael; Hausch, Felix. (2023) Novel FKBP12 targeting PROTACs enhance BMP-induced apoptosis in multiple myeloma. IMS 20th International Myeloma Workshop 2023-09-27 - 2023-09-29
-
Academic lectureHolien, Toril. (2023) Ways of regulating ALK2 activity in multiple myeloma cells. Uppsala University Rudbeck Seminar Series 2023-06-08 - 2023-06-08
2022
-
PosterAndersson-Rusch, Clara; Liu, Bin; Quist-Løkken, Ingrid; Upton, Paul D.; Olsen, Oddrun Elise; Hella, Hanne. (2022) Soluble endoglin inhibits BMP9 signaling in non-endothelial cells. 13th International BMP Conference 2022-10-08 - 2022-10-12
-
PosterQuist-Løkken, Ingrid; Andersson-Rusch, Clara; Kastnes, Martin Haugrud; Kolos, Jürgen M; Jatzlau, Jerome; Hella, Hanne. (2022) FKBP12 regulates signal strength and specificity of bone morphogenetic protein activation via ALK2. 13th International BMP Conference 2022-10-08 - 2022-10-12
-
Academic lectureQuist-Løkken, Ingrid; Andersson-Rusch, Clara; Kastnes, Martin Haugrud; Kolos, Jürgen M; Jatzlau, Jerome; Hella, Hanne. (2022) FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells. 13th International BMP Conference 2022-10-08 - 2022-10-12
-
Academic lectureQuist-Løkken, Ingrid; Andersson-Rusch, Clara; Kastnes, Martin Haugrud; Kolos, Jürgen M; Jatzlau, Jerome; Hella, Hanne. (2022) FKBP12 is a major regulator of ligand dependent ALK2 activity in multiple myeloma cells. FASEB The TGF-β Superfamily Conference: Signaling in Development and Disease , Malahide 2022-07-17 - 2022-07-21
-
PosterChristensen, Eidi; Foss, Olav A.; Quist-Paulsen, Petter; Staur, Ingrid; Pettersen, Frode; Holien, Toril. (2022) PDT with 5-ALA to extracorporeal photopheresis in the treatment of patients with graft-versus-host disease; a phase I study. The European Society for Photodynamic Therapy 20th Annual Congress, Euro-PDT , Paris 2022-06-17 - 2022-06-18
2021
-
PosterQuist-Løkken, Ingrid; Andersson-Rusch, Clara; Olsen, Oddrun Elise; Holien, Toril. (2021) FK506 potentiates ligand-induced ALK2 activity in multiple myeloma cells. FASEB The TGF-β Superfamily Conference: Signaling in Development and Disease , Virtual 2021-07-20 - 2021-07-21
-
Academic lectureHolien, Toril. (2021) Regulating the tumor suppressing activity of ALK2 in multiple myeloma. NTNU 3rd International NTNU Symposium on Clinical Biomarkers of Cancer 2021-06-15 - 2021-06-17
2020
-
Academic lectureHolien, Toril. (2020) Regulating the tumor suppressing activity of ALK2 in multiple myeloma. BMP Conference Dubrovnik 2020 1st Virtual BMP Forum, Session 3: BMP Signalling in Cancer 2020-11-04 - 2020-11-04
2019
-
Academic lectureChristensen, Eidi; Holien, Toril; Juzenas, Petras; Oksvold, Morten Pedersen; Darvekar, Sagar; Qian, Peng. (2019) Extracorporal photopheresis using 5-aminolevulinic acid in patients with cronic graft-versus-host disease - preliminary results from a pilot study. International League of Dermatological Societies (ILDS) 24th World Congress of Dermatology , Milano 2019-06-10 - 2019-06-15
-
Academic lectureHolien, Toril; Westhrin, Marita; Zahoor, Muhammad; Moen, Siv Helen; Buene, Glenn; Størdal, Berit Fladvad. (2019) BMP4 gene therapy in mice inhibits myeloma tumor growth, but has a negative impact on bone. . FASEB The TGF-β Superfamily: Signaling in Development and disease. , West Palm Beach, FL 2019-07-28 - 2019-08-02
-
PosterChristensen, Eidi; Holien, Toril; Juzenas, Petras; Oksvold, Morten Pedersen; Darvekar, Sagar; Qian, Peng. (2019) Extracorporal Photopheresis using 5-Aminolevulinic Acid of Patients with cronic Graft-Versus-Host Disease. Nordic Dermatology Association 34th Nordic congress of Dermatology and Venereology , Gøteborg 2019-05-08 - 2019-05-10
-
Academic lectureHolien, Toril. (2019) Bone morphogenetic proteins as possible treatment for multiple myeloma?. Dep. of Medical Biochemistry and Microbiology, Uppsala Univ. Tumor biology seminar series , Uppsala 2019-02-06 - 2019-02-06
-
Academic lectureHolien, Toril. (2019) Kan benmorfogene proteiner utnyttes i behandling av myelomatose?. Norsk Selskap for Hematologi Hematologisk Vintermøte , Trondheim 2019-03-14 - 2019-03-14
-
Academic lectureHolien, Toril; Westhrin, Marita; Zahoor, Muhammad; Moen, Siv Helen; Buene, Glenn; Størdal, Berit Fladvad. (2019) BMP4 gene therapy in mice inhibits myeloma tumor growth, but has a negative impact on bone . Biochemical Society BMP Signalling in Cancer II , Oxford 2019-04-01 - 2019-04-03
-
Academic lectureHolien, Toril. (2019) Kan benmorfogene proteiner brukes i behandling av beinmargskreft?. Seksjon Immunologi-cytometri, St. Olavs Hospital Fagseminar Immunologi-cytometri-allergi , Trondheim 2019-03-26 - 2019-03-26
-
PosterOlsen, Oddrun Elise; Elsaadi, Samah; Hella, Hanne; Holien, Toril. (2019) Activins as dual-specificity TGF-β family molecules: Activation of activin- and BMP-type I receptors. FASEB The TGF-β Superfamily: Signaling in Development and Disease , West Palm Beach, FL 2019-07-28 - 2019-08-02
-
Academic lectureHolien, Toril. (2019) Increasing the activity of bone morphogenetic proteins as a treatment strategy in multiple myeloma. Norwegian Myeloma Workshop , Trondheim 2019-10-17 - 2019-10-18
2018
-
Academic lectureGederaas, Odrun Arna; Holien, Toril; Darvekar, Sagar; Christensen, Eidi; Qian, Peng. (2018) Comparison between 8-methoxypsoralen and 5-aminolevulinic acid in killing T cells of photopheresis patients ex vivo. Center at Urology Dept. of Klinikum. Univ. of Munchen Photodynamic Therapy and Photodiagnosis Update 2018 , Kochel am See, Tyskland 2018-09-12 - 2018-09-14
-
PosterHolien, Toril; Westhrin, Marita; Moen, Siv Helen; Zahoor, Muhammad; Buene, Glenn; Størdal, Berit Fladvad. (2018) BMP4 gene therapy inhibits myeloma tumor growth, but has a negative impact on bone. 12th International BMP Conference , Tokyo 2018-10-24 - 2018-10-28
-
PosterHolien, Toril; Westhrin, Marita; Moen, Siv Helen; Buene, Glenn; Groen, Richard WJ; Martens, Anton. (2018) BMP4 gene therapy inhibits myeloma tumor growth, but has a negative impact on bone. 2nd International NTNU Symposium Current and Future Clinical Biomarkers of Cancer: From diagnosis to immunotherapy – why is precision medicine so difficult? 2018-06-14 -
-
PosterHolien, Toril; Westhrin, Marita; Moen, Siv Helen; Zahoor, Muhammad; Buene, Glenn; Størdal, Berit Fladvad. (2018) BMP4 Gene Therapy Inhibits Myeloma Tumor Growth, but Has a Negative Impact on Bone. The American Society of Hematology ASH 2018 , San Diego 2018-12-01 - 2018-12-04
-
PosterOlsen, Oddrun Elise; Sankar, Meenu; Elsaadi, Samah; Hella, Hanne; Darvekar, Sagar; Misund, Kristine. (2018) BMPR2 inhibits activin- and BMP-signaling via wild type ALK2. NTNU 2nd International NTNU Symposium Current and Future Clinical Biomarkers of Cancer: From diagnosis to immunotherapy – why is precision medicine so difficult? , Trondheim 2018-06-14 - 2018-06-15
2017
-
Academic lectureOlsen, Oddrun Elise; Sankar, Meenu; Darvekar, Sagar; Misund, Kristine; Sundan, Anders; Holien, Toril. (2017) Activins induce apoptosis through wild type ALK2/ACVR1 and are counteracted by BMPR2. FASEB The TGFb Superfamily: Signaling in Development and Disease , Lisboa 2017-07-09 - 2017-07-14
-
Academic lectureOlsen, Oddrun Elise; Sankar, Meenu; Elsaadi, Samah; Hella, Hanne; Darvekar, Sagar; Misund, Kristine. (2017) Activins induce apoptosis through wild type ALK2/ACVR1 and are counteracted by BMPR2. Nordic Myeloma Study Group NMSG plenary meeting , Trondheim 2017-09-07 - 2017-09-08
-
Academic lectureHolien, Toril. (2017) BMPR2 inhibits activin- and BMP-induced apoptosis via ALK2 in myeloma cells. Department meeting IKOM 2017-10-25 - 2017-10-25
-
Academic lectureHolien, Toril. (2017) Bone morphogenetic proteins as possible treatment for multiple myeloma?. SFB 958 Interdisciplinary Lecture Series 2017 Having a look beyond the borders - methods and more , Freie Universität, Berlin 2017-03-09 - 2017-03-09
2016
-
PosterRustad, Even Holth; Coward, Eivind; Skytøen, Emilie R; Misund, Kristine; Holien, Toril; Standal, Therese. (2016) Circulating Tumor DNA in Multiple Myeloma . European Hematology Association European Hematology Association 21th Congress , Copenhagen 2016-06-09 - 2016-06-12
-
PosterOlsen, Oddrun Elise; Sankar, Meenu; Darvekar, Sagar; Sundan, Anders; Holien, Toril. (2016) Potentiation of TGF-β superfamily ligands in myeloma cells by knockdown of BMPR2. 11th International BMP Meeting , Boston 2016-10-26 - 2016-10-30
-
Popular scientific lectureSlørdahl, Tobias Schmidt; Grøseth, Lill Anny Gunnes; Holien, Toril. (2016) Forskning på myelomatose. Klassebesøk, 3. trinn v.g.s. med fordypning i biologi 2016-05-03 - 2016-05-03
-
PosterOlsen, Oddrun Elise; Wader, Karin Fahl; Hella, Hanne; Waage, Anders; Sundan, Anders; Holien, Toril. (2016) Activin A inhibits BMP-signalling by binding ACVR2A and ACVR2B. The Biochemical Society, UK BMP Signalling in Cancer , Cambridge 2016-03-15 - 2016-03-17
-
PosterWolowczyk, Camilla; Appiah, Christiana; Mildenberger, Jennifer; Neckmann, Ulrike; Bjørkøy, Geir; Holien, Toril. (2016) Bmp4 and Grem1 in breast cancer tumor-stroma communication. UiT The 52nd NBS contact meeting , Tromsø 2016-01-21 - 2016-01-24
2015
-
Academic lectureHolien, Toril; Olsen, Oddrun Elise; Skjærvik, Anette; Sundan, Anders. (2015) Identification of receptors for GDF15. FASEB The TGFb Superfamily: Signaling in Development and Disease 2015-07-12 - 2015-07-17
-
PosterOlsen, Oddrun Elise; Wader, Karin Fahl; Hella, Hanne; Waage, Anders; Sundan, Anders; Holien, Toril. (2015) Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B. FASEB The TGFb Superfamily: Signaling in Development and Disease 2015-07-12 - 2015-07-17
-
PosterMisund, Kristine; Baranowska, Katarzyna Anna; Holien, Toril; Starheim, Kristian K.; Johansson, Ida; Buene, Glenn. (2015) Chloroquine potentiates Carfilzomib but not Bortezomib effects on myeloma cells. AACR 106th Annual Meeting 2015 , Philadelphia, PA 2015-04-18 - 2015-04-22
-
Academic lectureRustad, Even Holth; Coward, Eivind; Skytøen, Emilie R; Misund, Kristine; Holien, Toril; Dai, Hong Yan. (2015) Exome sequencing of tumor samples as starting point for monitoring mutations in circulating DNA of patients with multiple myeloma. NCGC Norwegian Cancer Genomics Consortium (NCGC) Symposium , Oslo 2015-10-27 - 2015-10-28
-
Academic lectureWesthrin, Marita; Moen, Siv Helen; Holien, Toril; Olsen, Oddrun Elise; Sundan, Anders; Waage, Anders. (2015) Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease. The international myeloma society 15th international myeloma workshop , Roma 2015-09-23 - 2015-09-25
-
Academic lectureRustad, Even Holth; Coward, Eivind; Skytøen, Emilie R; Misund, Kristine; Holien, Toril; Dai, Hong Yan. (2015) Detection and Monitoring of BRAF and NRAS Mutant Clones in Myeloma Patients by Digital PCR of Circulating DNA. NMSG Nordic Myeloma Study Group (NMSG) Annual Meeting , Stockholm 2015-11-12 - 2015-11-13
-
Popular scientific lectureMisund, Kristine; Grøseth, Lill Anny Gunnes; Holien, Toril. (2015) Forskning på myelomatose. Klassebesøk, 3. trinn v.g.s. med fordypning i biologi 2015-03-18 - 2015-03-18
2014
-
Interview
-
Interview
-
Popular scientific lectureHolien, Toril; Grøseth, Lill Anny Gunnes; Standal, Therese; Misund, Kristine; Bruvoll, Ingrid; Nordrum, Ivar Skjåk. (2014) Hvordan jobber en kreftforsker + Besøk i medisinsk museum i Kunnskapssenteret. Klassebesøk, 5. trinn barneskole 2014-03-19 - 2014-03-19
-
PosterHolien, Toril; Misund, Kristine; Buene, Glenn; Olsen, Oddrun Elise; Baranowska, Katarzyna Anna; Waage, Anders. (2014) MYC gene copy number determine MYC expression and sensitivity to a MYC-inhibitor in multiple myeloma cells. American Association for Cancer Research AACR Annual Meeting 2014 , San Diego, CA 2014-04-05 - 2014-04-09
-
InterviewSundan, Anders; Holien, Toril. (2014) Fikk millionstøtte til kreftforskning . Trønderavisa Trønderavisa [Internet] 2014-10-30
2013
-
PosterOlsen, Oddrun Elise; Wader, Karin Fahl; Misund, Kristine; Våtsveen, Thea Kristin; Rø, Torstein Baade; Størdal, Berit Fladvad. (2013) Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin. FASEB TGF-B Superfamily: Signaling in Development and Disease 2013-07-28 - 2013-08-02
-
Popular scientific lectureHolien, Toril; Sponaas, Anne-Marit; Misund, Kristine; Rø, Torstein Baade; Brede, Gaute; Standal, Therese. (2013) "Ta livet av kreftcellene" Stand i samarbeid med Kreftforeningen. NTNU - Forskningsdagene Forskningstorget , Trondheim 2013-09-20 - 2013-09-21
-
Interview
-
PosterHolien, Toril; Våtsveen, Thea Kristin; Hella, Hanne; Waage, Anders; Sundan, Anders. (2013) Dependency on c-MYC in multiple myeloma. American Association for Cancer Research AACR Annual Meeting 2013 , Washington, D.C. 2013-04-06 - 2013-04-10
-
LectureOlsen, Oddrun Elise; Wader, Karin Fahl; Misund, Kristine; Våtsveen, Thea Kristin; Rø, Torstein Baade; Størdal, Berit Fladvad. (2013) Membrane bound and soluble endoglin protects myeloma cells from bone morphogenetic protein 9 induced apoptosis. NBS vintermøte 2013-01-17 - 2013-01-20
2012
-
Academic lectureBørset, Magne; Holt, Randi Utne; Slørdahl, Tobias Schmidt; Holien, Toril; Dai, Hong Yan; Sundan, Anders. (2012) PRL-3 - A Microenvironment-responsive Phosphatase in Myeloma Cells with Oncogenic Capacity. BIT’s 1st Annual International Symposium of Hematology-2012 (AISH2012) , Beijing 2012-06-15 -
-
PosterMisund, Kristine; Baranowska, Katarzyna Anna; Holien, Toril; Rampa, Christoph Samuel; Klein, Dionne; Børset, Magne. (2012) A Method for Measurement of Drug Sensitivity of Myeloma Cells Co-Cultured with Bone Marrow Stromal Cells. American Society of Hematology The American Society of Hematology (ASH) annual meeting , Atlanta, Georgia 2012-12-07 - 2012-12-11
-
Academic lectureHolien, Toril. (2012) Growth inhibition of myeloma cells by bone morphogenic protein 9 is inhibited by endoglin. Onsdagsmøte, IKM 2012-05-23 - 2012-05-23
-
PosterMisund, Kristine; Baranowska, Katarzyna Anna; Holien, Toril; Rampa, Christoph Samuel; Waage, Anders; Sundan, Anders. (2012) Attempts to predict response to cytostatics in Multiple Myeloma patients. Norwegian Biochemical Society Norwegian Biochemical Society Contact Meeting , Storefjell 2012-01-19 - 2012-01-22
-
Academic lectureHolien, Toril; Våtsveen, Thea Kristin; Hella, Hanne; Waage, Anders; Sundan, Anders. (2012) Dependency on c-MYC in multiple myeloma. BIT's 1st Annual International Symposium of Hematology (AISH-2012) , Beijing 2012-06-15 - 2012-06-17
-
InterviewHolien, Toril. (2012) – Må jobbes videre for å finne gode MYC-hemmere. Aktuelt, St. Olavs Hospital Aktuelt, St. Olavs Hospital [Internet] 2012-03-05
-
Academic lectureHolien, Toril. (2012) Pasientmateriale til forskning på myelomatose. Avdeling for blodsykdommer Lunsjforedrag , St. Olavs Hospital, Trondheim 2012-03-30 - 2012-03-30
2011
-
PosterRø, Torstein Baade; Holt, Randi Utne; Holien, Toril; Fagerli, Unn-Merete; Hov, Håkon; Waage, Anders. (2011) HGF AND IGF-1 POTENTIATE SDF-1 ALPHA-MEDIATED MYELOMA CELL MIGRATION THROUGH ACTIVATION OF PAK. 13th international myeloma workshop , Paris 2011-05-04 - 2011-05-08
-
Academic lectureHolien, Toril. (2011) Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by MYC downregulation. Onsdagsmøte, IKM 2011-01-19 - 2011-01-19
-
PosterHolien, Toril; Våtsveen, Thea Kristin; Hella, Hanne; Rampa, Christoph Samuel; Brede, Gaute; Grøseth, Lill Anny Gunnes. (2011) BONE MORPHOGENETIC PROTEINS INDUCE APOPTOSIS BY SMAD-DEPENDENT DOWNREGULATION OF MYC. 13th Interntional Myeloma Workshop 2011-05-03 - 2011-05-06
2010
-
PosterFagerli, Unn-Merete; Stühmer, Thorsten; Holien, Toril; Holt, Randi Utne; Bruland, Ove; Chatterjee, Manik. (2010) Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Is a Prominent Target Gene of the Transcriptional Response to Cytokines In Multiple Myeloma and Supports the Growth of Myeloma Cells. American Society of Hematology ASH Annual Meeting 2010 , Orlando, Florida 2010-12-04 - 2010-12-07
-
PosterHolien, Toril; Rekvig, Magne; Våtsveen, Thea Kristin; Brenne, Anne-Tove; Rø, Torstein Baade; Waage, Anders. (2010) Interleukins mediate protection against BMP-induced apoptosis in multiple myeloma. 8th international conference on bone morphogenetic proteins , Leuven 2010-09-15 - 2010-09-18
-
Popular scientific lectureHolien, Toril. (2010) Drap av ondartede plasmaceller. Kreftforeningen Forskningssamling , Trondheim 2010-03-22 - 2010-03-22
2009
-
Academic lectureHolien, Toril. (2009) Mechanisms for BMP induced apoptosis in multiple myeloma. IKM Tirsdagsmøte for IKM 2009-04-21 - 2009-04-21
-
Academic lectureHolien, Toril. (2009) Bone morphogenetic proteins induce apoptosis in multiple myeloma by MYC downregulation. Norsk biokjemisk forening avd. Trøndelag Høstmøtet i NBS trøndelag , Selbu 2009-10-05 - 2009-10-06
-
PosterHov, Håkon; Tian, Erming; Holien, Toril; Holt, Randi Utne; Våtsveen, Thea; Fagerli, Unn-Merete. (2009) c-Met signaling promotes IL-6 induced myeloma cell proliferation. European Hematology Association 14th Congress , Germany, Berlin 2009-06-04 - 2009-06-07
-
PosterHolt, Randi Utne; Fagerli, Unn-Merete; Holien, Toril; Hov, Håkon; Waage, Anders; Sundan, Anders. (2009) HGF and IGF-1 potentiate SDF-1 mediated myeloma cell migration through activation of PAK. European Hematology Association 14th Congress , Berlin, Germany 2009-06-04 - 2009-06-07
-
PosterHolien, Toril; Brede, Gaute; Våtsveen, Thea Kristin; Børset, Magne; Waage, Anders; Sundan, Anders. (2009) Bone morphogenetic proteins induce downregulation of c-Myc and c-Myc target genes in multiple myeloma. FASEB The TGF-beta superfamily: Signaling in development and disease. , Carefree, Arizona 2009-06-14 - 2009-06-19
2008
-
Academic lectureHolien, Toril. (2008) Retroviral transduction of myeloma cell lines. Fellesmøte Toll/myelom 2008-12-05 - 2008-12-05
2005
-
PosterRø, Torstein Baade; Holien, Toril; Røsbak, Randi; Bohnhorst, Janne Øvrebø; Waage, Anders; Børset, Magne. (2005) THE MECHANISM OF BMP-INDUCED APOPTOSIS IN MYELOMA CELLS: A ROLE FOR p53. 10th INTERNATIONAL MYELOMA WORKSHOP , Sydney 2005-04-10 - 2005-04-14